U.S. flag

An official website of the United States government

GTR Home > Tests > CYP2D6 genotyping

Overview

Test name

Help

CYP2D6 genotyping (CYP2D6)

Purpose of the test

Help

This is a clinical test intended for Help: Drug Response, Therapeutic management

Condition

Help

Click Indication tab for more information.

How to order

Help

Please fill in the contact form at https://sinochipsdiagnostics.com/contact/ or give us a call (877) 746-6244.
Order URL Help: https://sinochipsdiagnostics.com/contact/

Specimen source

Buccal swab
Isolated DNA
Plasma

Methodology

Help
Molecular Genetics
TTargeted variant analysis
RT-PCR

Summary of what is tested

Click Methodology tab for more information.

Clinical utility

Help

Not provided

Clinical validity

Help

Not provided

Practice guidelines

  • DailyMed Drug Label, 2021
    DailyMed Drug Label, AMITRIPTYLINE HYDROCHLORIDE, 2021
  • CPIC, 2017
    Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
  • CPIC, 2013
    Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. (See 2016 Update)
  • DailyMed Drug Label, 2012
    DailyMed Drug Label, amitriptyline, 2012
  • DPWG, 2011
    Pharmacogenetics: from bench to byte--an update of guidelines.

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.